Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
2 recherche sur le mot-clé 'Healthcare costs'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Healthcare Service Use and Costs for Autism Spectrum Disorder: A Comparison Between Medicaid and Private Insurance / Li WANG in Journal of Autism and Developmental Disorders, 43-5 (May 2013)
[article]
Titre : Healthcare Service Use and Costs for Autism Spectrum Disorder: A Comparison Between Medicaid and Private Insurance Type de document : Texte imprimé et/ou numérique Auteurs : Li WANG, Auteur ; David S. MANDELL, Auteur ; Lindsay LAWER, Auteur ; Zuleyha CIDAV, Auteur ; Douglas L. LESLIE, Auteur Article en page(s) : p.1057-1064 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder Children Healthcare costs Service use Medicaid Private insurance Index. décimale : PER Périodiques Résumé : Healthcare costs and service use for autism spectrum disorder (ASD) were compared between Medicaid and private insurance, using 2003 insurance claims data in 24 states. In terms of costs and service use per child with ASD, Medicaid had higher total healthcare costs (22,653vs. 5,254), higher ASD-specific costs (7,438vs. 928), higher psychotropic medication costs(1,468vs. 875), more speech therapy visits (13.0 vs. 3.6 visits), more occupational/physical therapy visits (6.4 vs. 0.9 visits), and more behavior modification/social skills visits (3.8 vs. 1.1 visits) than private insurance (all p 0.0001). In multivariate analysis, being enrolled in Medicaid had the largest effect on costs, after controlling for other variables. The findings emphasize the need for continued efforts to improve private insurance coverage of autism. En ligne : http://dx.doi.org/10.1007/s10803-012-1649-y Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=195
in Journal of Autism and Developmental Disorders > 43-5 (May 2013) . - p.1057-1064[article] Healthcare Service Use and Costs for Autism Spectrum Disorder: A Comparison Between Medicaid and Private Insurance [Texte imprimé et/ou numérique] / Li WANG, Auteur ; David S. MANDELL, Auteur ; Lindsay LAWER, Auteur ; Zuleyha CIDAV, Auteur ; Douglas L. LESLIE, Auteur . - p.1057-1064.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 43-5 (May 2013) . - p.1057-1064
Mots-clés : Autism spectrum disorder Children Healthcare costs Service use Medicaid Private insurance Index. décimale : PER Périodiques Résumé : Healthcare costs and service use for autism spectrum disorder (ASD) were compared between Medicaid and private insurance, using 2003 insurance claims data in 24 states. In terms of costs and service use per child with ASD, Medicaid had higher total healthcare costs (22,653vs. 5,254), higher ASD-specific costs (7,438vs. 928), higher psychotropic medication costs(1,468vs. 875), more speech therapy visits (13.0 vs. 3.6 visits), more occupational/physical therapy visits (6.4 vs. 0.9 visits), and more behavior modification/social skills visits (3.8 vs. 1.1 visits) than private insurance (all p 0.0001). In multivariate analysis, being enrolled in Medicaid had the largest effect on costs, after controlling for other variables. The findings emphasize the need for continued efforts to improve private insurance coverage of autism. En ligne : http://dx.doi.org/10.1007/s10803-012-1649-y Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=195 Continuity of health anxiety from childhood to adolescence and associated healthcare costs: a prospective population-based cohort study / Martin K. RIMVALL in Journal of Child Psychology and Psychiatry, 62-4 (April 2021)
[article]
Titre : Continuity of health anxiety from childhood to adolescence and associated healthcare costs: a prospective population-based cohort study Type de document : Texte imprimé et/ou numérique Auteurs : Martin K. RIMVALL, Auteur ; Pia JEPPESEN, Auteur ; Anne Mette SKOVGAARD, Auteur ; Frank VERHULST, Auteur ; Else Marie OLSEN, Auteur ; Charlotte Ulrikka RASK, Auteur Article en page(s) : p.441-448 Langues : Anglais (eng) Mots-clés : Health anxiety childhood and adolescence healthcare costs longitudinal cohort Index. décimale : PER Périodiques Résumé : BACKGROUND: Severe health anxiety (HA) is characterized by excessive and impairing worry and preoccupation with health issues and can cause increased and unnecessary medical examinations. HA in childhood and adolescence is scarcely explored, hindering the potential for prevention and early intervention. METHODS: HA was assessed in 1,278 children/youths at two time points at ages 11 and 16 years in a general population-based birth cohort. Register-based data on costs related to nonhospital-based primary and secondary somatic health services were obtained over the follow-up period. The presence of functional somatic symptoms, emotional disorders and chronic somatic illness at baseline were included as covariates. RESULTS: High HA (top 10% score) at age 11 predicted high HA at age 16 (relative risk [RR] 2.03, 95% CI: 1.26-3.31). The group with persistent HA was small (n = 17, 1.3%), resulting in broad confidence intervals. The statistical effect of HA at age 11 on HA at age 16 was heavily reduced after adjustment for sex and all covariates (RR: 1.49, 95% CI: 0.85-2.60). In the adjusted model, somatic illness at age 11 (RR: 1.91, 95% CI: 1.22-2.98) and female sex (RR: 3.33, 95% CI: 2.01-5.50) were independently associated with HA at age 16. Persistent HA was associated with approximately doubled healthcare costs compared to the group with consistently low HA. Incident HA at age 16 was associated with increased costs over follow-up. The increased costs were not explained by chronic somatic illness. CONCLUSIONS: A small subgroup of children had persistent high levels of HA from late childhood to adolescence and displayed increased healthcare costs. Female sex and chronic somatic disorders at age 11 were independent risk factors of HA at age 16. These findings provide potential means of early identification and of therapeutic levers. Further intervention development and evaluation are needed. En ligne : http://dx.doi.org/10.1111/jcpp.13286 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=445
in Journal of Child Psychology and Psychiatry > 62-4 (April 2021) . - p.441-448[article] Continuity of health anxiety from childhood to adolescence and associated healthcare costs: a prospective population-based cohort study [Texte imprimé et/ou numérique] / Martin K. RIMVALL, Auteur ; Pia JEPPESEN, Auteur ; Anne Mette SKOVGAARD, Auteur ; Frank VERHULST, Auteur ; Else Marie OLSEN, Auteur ; Charlotte Ulrikka RASK, Auteur . - p.441-448.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 62-4 (April 2021) . - p.441-448
Mots-clés : Health anxiety childhood and adolescence healthcare costs longitudinal cohort Index. décimale : PER Périodiques Résumé : BACKGROUND: Severe health anxiety (HA) is characterized by excessive and impairing worry and preoccupation with health issues and can cause increased and unnecessary medical examinations. HA in childhood and adolescence is scarcely explored, hindering the potential for prevention and early intervention. METHODS: HA was assessed in 1,278 children/youths at two time points at ages 11 and 16 years in a general population-based birth cohort. Register-based data on costs related to nonhospital-based primary and secondary somatic health services were obtained over the follow-up period. The presence of functional somatic symptoms, emotional disorders and chronic somatic illness at baseline were included as covariates. RESULTS: High HA (top 10% score) at age 11 predicted high HA at age 16 (relative risk [RR] 2.03, 95% CI: 1.26-3.31). The group with persistent HA was small (n = 17, 1.3%), resulting in broad confidence intervals. The statistical effect of HA at age 11 on HA at age 16 was heavily reduced after adjustment for sex and all covariates (RR: 1.49, 95% CI: 0.85-2.60). In the adjusted model, somatic illness at age 11 (RR: 1.91, 95% CI: 1.22-2.98) and female sex (RR: 3.33, 95% CI: 2.01-5.50) were independently associated with HA at age 16. Persistent HA was associated with approximately doubled healthcare costs compared to the group with consistently low HA. Incident HA at age 16 was associated with increased costs over follow-up. The increased costs were not explained by chronic somatic illness. CONCLUSIONS: A small subgroup of children had persistent high levels of HA from late childhood to adolescence and displayed increased healthcare costs. Female sex and chronic somatic disorders at age 11 were independent risk factors of HA at age 16. These findings provide potential means of early identification and of therapeutic levers. Further intervention development and evaluation are needed. En ligne : http://dx.doi.org/10.1111/jcpp.13286 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=445